Tower Research Capital (TRC)’s Revolution Medicines RVMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$361K	Buy	3,711 +3,519	+1,833%	+$355K	0.01%	1168
2025 Q4	$15.3K	Sell	192 -4,427	-96%	-$290K	﹤0.01%	3296
2025 Q3	$216K	Sell	4,619 -66,915	-94%	-$2.62M	0.01%	1399
2025 Q2	$2.63M	Buy	71,534 +61,199	+592%	+$2.35M	0.07%	249
2025 Q1	$365K	Sell	10,335 -8,144	-44%	-$331K	0.01%	1029
2024 Q4	$808K	Buy	18,479 +16,087	+673%	+$812K	0.02%	744
2024 Q3	$108K	Sell	2,392 -23,662	-91%	-$1.03M	﹤0.01%	2159
2024 Q2	$1.01M	Buy	26,054 +24,641	+1,744%	+$921K	0.02%	766
2024 Q1	$45.5K	Sell	1,413 -7,132	-83%	-$211K	﹤0.01%	2344
2023 Q4	$245K	Sell	8,545 -12,146	-59%	-$292K	﹤0.01%	1935
2023 Q3	$573K	Buy	20,691 +17,746	+603%	+$526K	0.02%	798
2023 Q2	$78.8K	Sell	2,945 -473	-14%	-$11.6K	﹤0.01%	2226
2023 Q1	$74K	Buy	3,418 +1,481	+76%	+$36.5K	﹤0.01%	2152
2022 Q4	$46K	Sell	1,937 -4,014	-67%	-$85.3K	﹤0.01%	2418
2022 Q3	$117K	Sell	5,951 -368	-6%	-$8.09K	﹤0.01%	2436
2022 Q2	$123K	Sell	6,319 -1,120	-15%	-$21.8K	﹤0.01%	2125
2022 Q1	$190K	Sell	7,439 -44	-0.6%	-$958	﹤0.01%	1765
2021 Q4	$188K	Buy	7,483 +1,417	+23%	+$39.9K	﹤0.01%	1818
2021 Q3	$167K	Buy	6,066 +1,847	+44%	+$53.8K	﹤0.01%	1978
2021 Q2	$134K	Buy	4,219 +2,176	+107%	+$75.9K	﹤0.01%	2193
2021 Q1	$94K	Sell	2,043 -1,820	-47%	-$81.6K	﹤0.01%	2636
2020 Q4	$153K	Sell	3,863 -6,384	-62%	-$252K	﹤0.01%	1959
2020 Q3	$357K	Buy	10,247 +7,420	+262%	+$206K	﹤0.01%	2025
2020 Q2	$89K	Buy	+2,827	New	+$88.9K	﹤0.01%	2561